279 related articles for article (PubMed ID: 24851088)
1. Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer's Disease.
Dias KS; Viegas C
Curr Neuropharmacol; 2014 May; 12(3):239-55. PubMed ID: 24851088
[TBL] [Abstract][Full Text] [Related]
2. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
León R; Garcia AG; Marco-Contelles J
Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
[TBL] [Abstract][Full Text] [Related]
4. Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach.
Kumar S; Mahajan A; Ambatwar R; Khatik G
Curr Med Chem; 2023 Oct; ():. PubMed ID: 37861025
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease.
Pathak C; Kabra UD
Bioorg Chem; 2024 Mar; 144():107152. PubMed ID: 38290187
[TBL] [Abstract][Full Text] [Related]
6. Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease.
Campora M; Francesconi V; Schenone S; Tasso B; Tonelli M
Pharmaceuticals (Basel); 2021 Jan; 14(1):. PubMed ID: 33466332
[TBL] [Abstract][Full Text] [Related]
7. The multifactorial nature of Alzheimer's disease for developing potential therapeutics.
Carreiras MC; Mendes E; Perry MJ; Francisco AP; Marco-Contelles J
Curr Top Med Chem; 2013; 13(15):1745-70. PubMed ID: 23931435
[TBL] [Abstract][Full Text] [Related]
8. Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases.
Gontijo VS; Viegas FPD; Ortiz CJC; de Freitas Silva M; Damasio CM; Rosa MC; Campos TG; Couto DS; Tranches Dias KS; Viegas C
Curr Neuropharmacol; 2020; 18(5):348-407. PubMed ID: 31631821
[TBL] [Abstract][Full Text] [Related]
9. Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors.
Bolea I; Gella A; Unzeta M
J Neural Transm (Vienna); 2013 Jun; 120(6):893-902. PubMed ID: 23238976
[TBL] [Abstract][Full Text] [Related]
10. Multitarget Directed Ligand Approaches for Alzheimer's Disease: A Comprehensive Review.
Ramalakshmi N; R S R; C N N
Mini Rev Med Chem; 2021; 21(16):2361-2388. PubMed ID: 33820504
[TBL] [Abstract][Full Text] [Related]
11. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.
Kumar A; Tiwari A; Sharma A
Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413
[TBL] [Abstract][Full Text] [Related]
12. Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons.
Das S; Basu S
Curr Top Med Chem; 2017; 17(27):3017-3061. PubMed ID: 28685694
[TBL] [Abstract][Full Text] [Related]
13. A Novel Multifunctional 5,6-Dimethoxy-Indanone-Chalcone-Carbamate Hybrids Alleviates Cognitive Decline in Alzheimer's Disease by Dual Inhibition of Acetylcholinesterase and Inflammation.
Liu C; Sang Z; Pan H; Wu Q; Qiu Y; Shi J
Front Aging Neurosci; 2022; 14():922650. PubMed ID: 35860673
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Tacrine-Natural-Product Hybrids for Alzheimer's Disease Therapy.
Oset-Gasque MJ; Marco-Contelles JL
Curr Med Chem; 2020; 27(26):4392-4400. PubMed ID: 29611473
[TBL] [Abstract][Full Text] [Related]
16. Multi-target-directed ligands in Alzheimer's disease treatment.
Bajda M; Guzior N; Ignasik M; Malawska B
Curr Med Chem; 2011; 18(32):4949-75. PubMed ID: 22050745
[TBL] [Abstract][Full Text] [Related]
17. The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention.
Tolar M; Hey JA; Power A; Abushakra S
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473975
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
20. Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease.
Kumar N; Kumar V; Anand P; Kumar V; Ranjan Dwivedi A; Kumar V
Bioorg Med Chem; 2022 May; 61():116742. PubMed ID: 35398739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
